Abstract: User engagement has recently received significant attention in understanding the decay and expansion of communities in many online social networking platforms. Many user engagement studies ...
Vertex Pharmaceuticals chief Reshma Kewalramani said AI could reduce the time spent on drug-approval paperwork from months to ...
Vertex, Inc. shares have plunged over 60% YTD, but valuation is now compelling after a post-earnings dip. Learn more about VERX stock here.
Advocacy groups form a buyer’s club to obtain generic versions of pricey Vertex cystic fibrosis drug
Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...
With immunology and inflammation blockbusters like AbbVie’s Skyrizi and Rinvoq reeling in nearly $7 billion combined in the ...
Zacks Investment Research on MSN
Vertex Gears Up to Report Q3 Earnings: Is a Beat in the Cards?
We expect Vertex Pharmaceuticals VRTX to surpass expectations when it reports its third-quarter 2025 results on Nov. 3, after ...
Investor's Business Daily on MSN
Vertex Pharma's Mixed Quarter: How Legacy Products Drove Its Beat
Vertex stock dipped Tuesday on a mixed third-quarter report, with the lion's share of its sales beat coming from its older CF ...
While the launches of Journavx and Casgevy have started to build steam, “investors may not be inclined to look past the clear ...
A step-by-step guide to help you fill out a W-4 Nora Carol Photography / Getty Images IRS Form W-4 dictates how much money is withheld from your gross pay for taxes. Step 1 requires you to input ...
There is no stopping the Los Angeles Dodgers. Winning their 12th NL West title in 13 years, the Dodgers once again cruised into the postseason with major expectations, looking to win their second ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback